Back
ESC Premium Access

Increased thromboprophylactic treatment of patients with atrial fibrillation after the introduction of NOACs - an analysis of sex and gender differences

Session: Poster session 4 - Stroke prevention
Topic: Atrial fibrillation (AF)
Speaker: Ms D. Loikas (Stockholm, SE)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Ms Desiree Loikas

Karolinska Institute, Stockholm (Sweden)
0 follower

53 more presentations in this session

Differences between randomized controlled clinical trials and real-world atrial fibrillation patients treated with oral anticoagulants - do we treat the same patients? Results from the CRAFT study

Speaker: Doctor A. Tyminska (Warsaw, PL)

Access
Abstract
Slides
Like
Thumbnail

Which factors influence the choice of a non-vitamin K oral anticoagulant over warfarin for stroke prevention among atrial fibrillation patients? Insights from the prospective SPRINT-AF registry.

Speaker: Doctor M. Gupta (Toronto, CA)

Access
Abstract
Like
Thumbnail

Real-world effectiveness of stroke prevention in patients with non-valvular atrial fibrillation treated with rivaroxaban vs. phenprocoumon in germany - insights from the reload study

Speaker: Professor H. Bonnemeier (Luebeck, DE)

Access
Abstract
Slides
Like
Thumbnail

Comparison of stroke- and bleed-related healthcare resource utilization (HCRU) among patients with non-valvular atrial fibrillation (NVAF), newly treated with oral anti-coagulants (OACs)

Speaker: Doctor J. Franchino-Elder (Ridgefield, US)

Access
Abstract
Like
Thumbnail

Real-world single tertiary-care multidisciplinary experience with dabigatran, apixaban, rivaroxaban and warfarin in patients with renal failure and concomitant NVAF.

Speaker: Doctor F. Melillo (Milan, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 4 - Stroke prevention

Speakers: Ms D. Loikas, Doctor A. Tyminska, Doctor M. Gupta, Professor H. Bonnemeier, Doctor J. Franchino-Elder...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources